Results 11 to 20 of about 101,444 (326)
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
Journal of Clinical Medicine, 2022 The burden of atherosclerotic disease worldwide necessitates implementing the treatment of its risk factors. Among them, hypercholesterolemia has a central role.
C. Gareri +5 more
semanticscholar +1 more source
Antioxidants, 2021 Nutrition plays a fundamental role in the prevention and treatment of dyslipidemias and its oxidative-related complications. Currently, there is evidence about the beneficial effects of isolated antioxidants or foods enriched or added with antioxidant ...
I. Medina-Vera +6 more
semanticscholar +1 more source
Genes, 2021 The genetic screening program for familial hypercholesterolemia (FH) in the Netherlands, which was embraced by the Dutch Ministry of Health from 1994 to 2014, has led to twenty years of identification of at least 1500 FH cases per year.
L. Zuurbier, J. Defesche, A. Wiegman
semanticscholar +1 more source
Current Atherosclerosis Reports, 2021 This review aims to summarize the most recent published literature concerning lomitapide and volanesorsen that are approved for the use in HoFH and FCS patients, respectively. Moreover, it will briefly revise the published evidence on novel, non-approved
L. D’Erasmo, S. Bini, M. Arca
semanticscholar +1 more source
RNA Silencing in the Management of Dyslipidemias
Current Atherosclerosis Reports, 2021 Remarkable reductions in cardiovascular morbidity and mortality have been achieved in recent decades through the widespread use of ‘small-molecule’ hypolipidaemic drugs such as statins and ezetimibe.
N. C. Henney, M. Banach, Peter E. Penson
semanticscholar +1 more source
Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents
Journal of Nutrition and Metabolism, 2022 Dyslipidemias or dyslipoproteinemias are quantitative changes in total cholesterol concentration, respective fractions, or triglycerides in the plasma. Evidence supported that dyslipidemia in childhood is associated with atherosclerosis in adulthood, and
Sara Mosca +8 more
doaj +1 more source
Diabetes Therapy, 2016 Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular ...
Schofield, Jonathan D +4 more
openaire +2 more sources
Asian Journal of Surgery, 2020 Summary: Objective: Aim to explore the association of dyslipidemias with GBP prevalence, number and size in a large Chinese population in Beijing. Dyslipidemias include hypercholesterolemia, hypertriglyceridemia, increased low density lipoprotein (LDL ...
Zheng Yamin +5 more
doaj +1 more source
BMC Medical Genomics, 2020 In 2013, our laboratory designed a targeted sequencing panel, “LipidSeq”, to study the genetic determinants of dyslipidemia and metabolic disorders. Over the last 6 years, we have analyzed 3262 patient samples obtained from our own Lipid Genetics Clinic ...
J. Dron +7 more
semanticscholar +1 more source
Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012
Salud Pública de México, 2020 Objective. To describe in a national sample 1) the prevalence, awareness, treatment and control of dyslipidemias 2) the prevalence of dyslipidemias through previous national surveys. Materials and methods.
César Hernández-Alcaraz +8 more
doaj +1 more source